Developing a revolutionary endovascular flow diverter and coil-containment device for the minimally invasive treatment of bifurcation aneurysms
Click here to receive our slide deck. A letter from the CEO: NeuroMedica, Inc. is commercializing a novel, patented endovascular flow diverter for minimally invasive treatment of cerebral aneurysms at bifurcations. The Company addresses a large and growing market of approximately $500 million sales in 2019 with predicted compound annual growth rate (CAGR) in the 5-10% range. The FDA estimates about 5% of the US population is harboring a cerebral aneurysm. Our flow diverter is designed specifically to trea
Our physician advisory panel is headed up by Howard Riina, M.D. Dr. Riina is a Neurosurgeon, Professor of Neurosurgery, Neurology and Radiology; Vice Chairman, Department of Neurosurgery; and Director NYU Langone Center for Stroke and Neurovascular Diseases. Dr. Riina is also a co-founder of NeuroMedica. The other members of the Physician Advisory Board are Fernando Gonzalez, MD of Duke, Michael Lawton, MD, President & CEO Barrow Neurological Institute , and Narlin Beaty, MD, formerly at Johns Hopkins, now